QR Code

Diabetes Mellitus and Stroke: Pathophysiological Connections and Therapeutic Potential of GLP-1 and GLP-1/GIP Receptor Agonists

Both diabetes mellitus (DM) and stroke are major global health challenges with high morbidity and mortality. DM is a major risk factor for stroke, contributing to both increased incidence and worse clinical outcomes. Incretin-based therapies, including glucagon-like peptide-1 receptor agonists (GLP-...

Full description

Saved in:
Main Authors: Maria-Alexandra Paceana, Liliana Mititelu Tartau, Ianis Kevyn Stefan Boboc, Carmen Nicoleta Oancea, Anca Berbecaru-Iovan, Cezar Ilie Foia, Cosmin Gabriel Tartau, Maria Bogdan
Format: Artigo
Language:Inglês
Published: MDPI AG 2026-05-01
Series:Pharmaceutics
Subjects:
diabetes mellitus
stroke
antidiabetic drugs
GLP-1 receptor agonists
GLP-1/GIP receptor agonists
Online Access:https://www.mdpi.com/1999-4923/18/5/620
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items